AIM ImmunoTech Inc.

AIM · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$17,320-$28,962-$19,445-$19,127
Dep. & Amort.$246$238$256$805
Deferred Tax$0$5,839$197-$2,319
Stock-Based Comp.$686$243$954$1,568
Change in WC$296$1,065$966$895
Other Non-Cash$1,204$310$964$4,243
Operating Cash Flow-$14,888-$21,267-$16,108-$13,965
Investing Activities
PP&E Inv.-$18-$585-$271-$633
Net Acquisitions$0$47$3,900$592
Inv. Purchases-$361-$1,593-$2,724-$22,535
Inv. Sales/Matur.$5,716$1,299$10,083$22,292
Other Inv. Act.-$631$0$0-$347
Investing Cash Flow$4,706-$832$10,988-$631
Financing Activities
Debt Repay.$2,249$0$0-$4,854
Stock Issued$892$485$80$13,042
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3,303$0$0$0
Financing Cash Flow$6,444$485$80$8,188
Forex Effect$0$0$0$0
Net Chg. in Cash-$3,738-$21,614-$5,040-$6,408
Supplemental Information
Beg. Cash$5,439$27,053$32,093$38,501
End Cash$1,701$5,439$27,053$32,093
Free Cash Flow-$14,906-$21,852-$16,379-$14,598